Learning Objectives:

  1. Defining Resistant Hypertension (RH) and Its Pathophysiology
  2. Appraising   Aldosterone as a Mediator of RH
  3. Reviewing Aldosterone Synthase Inhibition As a Novel Treatment for RH

 

Faculty Disclosure:
Mason Freeman, MD has stock in CinCor Pharmaceuticals and Astra-Zeneca. 

Session date: 
06/07/2023 - 12:00pm to 1:00pm EDT
Location: 
Boston Medical Center
72 E. Concord Street
Collamore 8
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.